Ignite Creation Date:
2024-05-06 @ 7:35 PM
Last Modification Date:
2024-10-26 @ 3:09 PM
Study NCT ID:
NCT06062147
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-02-29
First Post:
2023-09-22
Brief Title:
Impact of Teacher Training and the Introduction of Early Adjustments on the Developmental Trajectory of Children at Risk of SLLD in Pre-school
Sponsor:
Centre Hospitalier Universitaire de la Réunion
Organization:
Centre Hospitalier Universitaire de la Réunion
Study Overview
Official Title:
Prevention Detection and Specialised Intervention in Pre-school Impact of Teacher Training and the Introduction of Early Adjustments on the Developmental Trajectory of Children at Risk of Specific Language and Learning Disorders SLLD
Status:
ACTIVE_NOT_RECRUITING
Status Verified Date:
2024-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
PRISME-TSLA
Brief Summary:
The high incidence of neurodevelopmental disorders including specific language and learning disorders and their profund impact on the schooling of the children concerned remains a major public health concern Early identification and intervention are a valuable tool for improving these problems The developmental trajectory of children could be improved by knowledge enhancement identification and strategies to support the teachers through the involvement of health professionals in the classroom
Detailed Description:
PRISME - TSLA is a clinical trial developing experiment project for the intervention arm involving teacher training the implementation of identification grids follow-up observations in classroom of identified pupils and the development of special arrangments For the control arm the teachers work with standard procedures of the French national education policy
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None